Accession Therapeutics

Accession Therapeutics is a novel immuno-oncology therapy company headquartered in Oxford, UK. Through the TROCEPT platform, we have designed new treatments that are expected to fundamentally address multiple issues caused by cancer cell diversity and escape mechanisms.